Halberd Corp. (HALB)
0.0013
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Halberd Debt to Equity Ratio : -0.1716 for Jan. 31, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| January 31, 2026 | -0.1716 |
| October 31, 2025 | -0.1765 |
| July 31, 2025 | -0.1643 |
| April 30, 2025 | -0.1644 |
| January 31, 2025 | -0.166 |
| October 31, 2024 | -0.1666 |
| July 31, 2024 | -0.1619 |
| April 30, 2024 | -0.1694 |
| January 31, 2024 | -0.1718 |
| October 31, 2023 | -0.167 |
| July 31, 2023 | -0.1619 |
| April 30, 2023 | -0.1624 |
| January 31, 2023 | -0.1598 |
| October 31, 2022 | -0.1704 |
| July 31, 2022 | -0.2061 |
| April 30, 2022 | -0.2435 |
| January 31, 2022 | -0.0181 |
| October 31, 2021 | -0.3208 |
| July 31, 2021 | -0.309 |
| April 30, 2021 | -0.866 |
| January 31, 2021 | -0.299 |
| October 31, 2020 | -0.2774 |
| July 31, 2020 | 0.00 |
| April 30, 2020 | 0.00 |
| January 31, 2020 | 0.00 |
| Date | Value |
|---|---|
| October 31, 2019 | 0.00 |
| January 31, 2019 | |
| October 31, 2018 | |
| July 31, 2017 | -0.7397 |
| April 30, 2017 | -5.882 |
| January 31, 2017 | -5.523 |
| October 31, 2016 | -0.9921 |
| July 31, 2016 | -1.088 |
| April 30, 2016 | -1.112 |
| January 31, 2016 | -1.101 |
| October 31, 2015 | -1.107 |
| July 31, 2015 | -1.115 |
| April 30, 2015 | -1.122 |
| January 31, 2015 | -1.136 |
| October 31, 2014 | -1.046 |
| July 31, 2014 | -0.865 |
| April 30, 2014 | -1.842 |
| January 31, 2014 | -3.202 |
| October 31, 2013 | -3.802 |
| July 31, 2013 | -3.680 |
| April 30, 2013 | -4.132 |
| January 31, 2013 | -41.14 |
| October 31, 2012 | 1626.67 |
| July 31, 2012 | -3.517 |
| April 30, 2012 | -3.535 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Agenus, Inc. | -1.458 |
| Amgen, Inc. | 4.903 |
| Altimmune, Inc. | 0.076 |
| AnaptysBio, Inc. | 25.47 |
| Aligos Therapeutics, Inc. | 0.1099 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 0.0041M |
| Total Liabilities (Quarterly) | 0.8783M |
| Shareholders Equity (Quarterly) | -0.8741M |
| Current Ratio | 0.0025 |